These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36505490)

  • 1. Corrigendum: DCBLD1 Overexpression is associated with a poor prognosis in head and neck squamous cell carcinoma.
    Fu LL; Yan M; Ma MX; Luo Y; Shao M; Gosau M; Friedrich RE; Vollkommer T; Feng HC; Smeets R
    Front Immunol; 2022; 13():1099835. PubMed ID: 36505490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCBLD1 Overexpression Is Associated With a Poor Prognosis in Head and Neck Squamous Cell Carcinoma.
    Fu LL; Yan M; Ma MX; Luo Y; Shao M; Gosau M; Friedrich RE; Vollkommer T; Feng HC; Smeets R
    Front Immunol; 2022; 13():939344. PubMed ID: 35844572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single Nucleotide Polymorphism rs6942067 Is a Risk Factor in Young and in Non-Smoking Patients with HPV Negative Head and Neck Squamous Cell Carcinoma.
    Cardin GB; Bernard M; Bahig H; Nguyen-Tan PF; Ballivy O; Filion E; Soulieres D; Philouze P; Ayad T; Guertin L; Bissada E; Rodier F; Christopoulos A
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31878157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma.
    Cardin GB; Bernard M; Rodier F; Christopoulos A
    Sci Rep; 2021 Jun; 11(1):12753. PubMed ID: 34140574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis.
    Zhang YZ; Zeb A; Cheng LF
    Front Immunol; 2023; 14():1168774. PubMed ID: 36926336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: Exosomes: Potential biomarkers and functions in head and neck squamous cell carcinoma.
    Li T; Li J; Wang H; Zhao J; Yan M; He H; Yu S
    Front Mol Biosci; 2022; 9():1056179. PubMed ID: 36406266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma.
    Lu T; Chen Y; Gong X; Guo Q; Lin C; Luo Q; Tu Z; Pan J; Li J
    Cancer Med; 2021 Nov; 10(21):7847-7862. PubMed ID: 34590792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Development of a phagocytosis- dependent gene signature to predict prognosis and response to checkpoint inhibition in clear-cell renal cell carcinoma.
    Li K; Li Y; Lyu Y; Tan L; Zheng X; Jiang H; Wen H; Feng C
    Front Immunol; 2023; 14():1140764. PubMed ID: 36742313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma.
    Yang ML; Zhang JH; Li S; Zhu R; Wang L
    Pathol Oncol Res; 2021; 27():1609967. PubMed ID: 34840533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():1047151. PubMed ID: 36325327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma.
    Yang Z; Li X; Li J; Su Q; Qiu Y; Zhang Z; Zhang L; Mo W
    Biomed Res Int; 2020; 2020():3962146. PubMed ID: 33083464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
    Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ
    Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study.
    Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M
    Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma.
    Cui K; Yao X; Wei Z; Yang Y; Liu X; Huang Z; Huo H; Tang J; Xie Y
    Front Genet; 2022; 13():917344. PubMed ID: 36186458
    [No Abstract]   [Full Text] [Related]  

  • 16. Identify metabolism-related genes IDO1, ALDH2, NCOA2, SLC7A5, SLC3A2, LDHB, and HPRT1 as potential prognostic markers and correlate with immune infiltrates in head and neck squamous cell carcinoma.
    Li C; Chen S; Jia W; Li W; Wei D; Cao S; Qian Y; Guan R; Liu H; Lei D
    Front Immunol; 2022; 13():955614. PubMed ID: 36090994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.
    Radhakrishnan A; Nanjappa V; Raja R; Sathe G; Puttamallesh VN; Jain AP; Pinto SM; Balaji SA; Chavan S; Sahasrabuddhe NA; Mathur PP; Kumar MM; Prasad TSK; Santosh V; Sukumar G; Califano JA; Rangarajan A; Sidransky D; Pandey A; Gowda H; Chatterjee A
    Sci Rep; 2017 Jun; 7():46864. PubMed ID: 28650432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma.
    Hu C; Fan J; He G; Dong C; Zhou S; Zheng Y
    PLoS One; 2022; 17(6):e0269166. PubMed ID: 35653344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck.
    Amit M; Liu C; Netto Gleber FO; Kini S; Tam S; Benov A; Aashiq M; El-Naggar AK; Moreno AC; Rosenthal DI; Glisson BS; Ferrarotto R; Wong MK; Migden MR; Li G; Khanna A; Goepfert RP; Nagarajan P; Weber RS; Myers JN; Gross ND
    Eur J Cancer; 2021 Feb; 144():169-177. PubMed ID: 33352413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck.
    Nishimura A; Yokota T; Hamauchi S; Onozawa Y; Shirasu H; Kawabata T; Ogawa H; Onoe T; Iida Y; Mukaigawa T; Yasui H
    Int J Clin Oncol; 2021 Oct; 26(10):1822-1830. PubMed ID: 34152533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.